Effect of current stimulation on memory, attention in diabetes
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2020/03/024399
- Lead Sponsor
- Abha Khisty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
1.Older adults diagnosed as type 2 Diabetes Mellitus more than 2 years and who are on oral antidiabetic medications.
2.Patients having HbA1c ranging from 6.0% to 8.5%, Recent reports of HbA1c i.e. within 1 month will be included.
3.Patients with score less than 24on Montreal cognitive assessment score
4 . Patients who have not undergone any supervised treatment protocol.
1.Diagnosed cases of any neurodegenerative disorders including dementia or Alzheimer’s disease
2.Patients with recent myocardial infarction ,cardiac pacemakers
3.Older adults with history or presence of retinopathy, neuropathy.
4. Impaired skin over the placement of electrode which includes eczema, rashes, blisters, open wounds, burn, and cuts.
5. Patients operated with implanted metallic plates or stimulators in brain.
6. Patients with the history of previous neurosurgical procedures, neurologic malformations or brain neoplasia.
7. Patients with any epileptic disorders.
8. Patients with carotid shunts, tooth implants and dentures, implants anywhere in head neck face
9.Patients with uncontrolled Diabetes Mellitus.
10. Patients with hypertension and cardiac pacemakers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Addenbrooke’s cognitive examination scoreTimepoint: Baseline at 0 Week and at 3 weeks
- Secondary Outcome Measures
Name Time Method Montreal cognitive assessment scale <br/ ><br>6 CIT scale <br/ ><br>Stroop test <br/ ><br>Timepoint: Baseline at 0 week and 3 weeks